Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Trial of Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia (The SURVENT Trial)

NCT05753748 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05753748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05753748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Trial of Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia (The SURVENT Trial)
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Recruiting
Start date
January 24, 2023
Completion date
April 30, 2029
Enrollment
680 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, barretts esophagus with dysplasia, esophageal adenocarcinoma